ALKERMES | ALKS - Kas Dan Setara





Kas Dan Setara Perubahan Tanggal
AbbVie USD 9.39B 4.16B 2026-03
Acadia Pharmaceuticals USD 851.46M 31.77M 2026-03
ALKERMES USD 511.53M 159.98M 2026-06
Amgen USD 12.04B 2.91B 2026-03
Biogen USD 1.28B 2.1B 2026-06
BioMarin Pharmaceutical USD 2.22B 910.76M 2026-03
Bristol-Myers Squibb USD 8.72B 852M 2026-06
Coherus Biosciences USD 88.88M 14.47M 2025-12
Eli Lilly USD 5.28B 1.99B 2026-03
Gilead Sciences USD 7.56B 234M 2025-12
Heron Therapeutics USD 26.12M 2.53M 2026-03
Ionis Pharmaceuticals USD 350.06M 1.57B 2026-06
J&J USD 20.42B 1.27B 2026-06
Malin Corporation EUR 62.1M 26.4M 2024-12
Merck USD 5.33B 9.24B 2026-03
Minerva Neurosciences USD 82.3M 70.02M 2025-12
Nektar Therapeutics USD 15.12M 25.92M 2025-12
Neurocrine Biosciences USD 332.4M 65.9M 2026-06
Otsuka Holdings JPY 534.64B 123.53B 2025-12
Pfizer USD 1.7B 561M 2026-03
Regeneron Pharmaceuticals USD 2.46B 506.8M 2026-06
Vertex Pharmaceuticals USD 7.25B 638.6M 2026-03